Long-Term Outcomes After Implantation of Magnesium-Based Bioresorbable Scaffolds—Insights From an All-Comer Registry

BackgroundThe magnesium-based sirolimus-eluting bioresorbable scaffold (Mg-BRS) Magmaris™ showed promising clinical outcomes, including low rates of both the target lesion failure (TLF) and scaffold thrombosis (ScT), in selected study patients. However, insights regarding long-term outcomes (>2 y...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Matthias Bossard, Mehdi Madanchi, Dardan Avdijaj, Adrian Attinger-Toller, Giacomo Maria Cioffi, Thomas Seiler, Gregorio Tersalvi, Richard Kobza, Guido Schüpfer, Florim Cuculi
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2022-04-01
Reeks:	Frontiers in Cardiovascular Medicine
Onderwerpen:	bioresorbable scaffold (BRS) Magmaris percutaneous coronary intervention scaffold thrombosis stent magnesium
Online toegang:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.856930/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!